CSIMarket
 
Alset Capital Acquisition Corp   (ACAXU)
Other Ticker:  
 
 
Price: $4.3000 $-6.25 -59.242%
Day's High: $9.5 Week Perf: -61.83 %
Day's Low: $ 4.00 30 Day Perf: -59.24 %
Volume (M): 9 52 Wk High: $ 28.01
Volume (M$): $ 40 52 Wk Avg: $10.16
Open: $9.50 52 Wk Low: $4.00



 Market Capitalization (Millions $) 11
 Shares Outstanding (Millions) 2
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 1
 Cash Flow (TTM) (Millions $) -2
 Capital Exp. (TTM) (Millions $) 0

Alset Capital Acquisition Corp
Alset Capital Acquisition Corp is a special purpose acquisition company (SPAC) formed to identify and acquire a target company. It is focused primarily on businesses in the life sciences and healthcare industries. The company was established with the goal of merging or acquiring a company with strong growth potential and value creation opportunities. Alset Capital Acquisition Corp aims to leverage its experienced management team and network to identify attractive investment opportunities in its target sectors.


   Company Address: 4800 Montgomery Lane Bethesda 20814 MD
   Company Phone Number: 971-3955   Stock Exchange / Ticker: NASDAQ ACAXU
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Alset Capital Acquisition Corp

Alset Capital Acquisition Corp: Third Quarter Earnings Reveal Troubling Operating Decline


As the financial results for the June to August 31, 2023 earnings cycle continue to roll in, investors are closely analyzing the performance of various entities across industries. Among them, one particular firm making headlines is Alset Capital Acquisition Corp in the Pharmacy Services & Retail Drugstore industry. With an operating shortfall of $-0.395777 million in this span, investors are left wondering about the potential revenues and the ability of this company to sustain its business model.
Comparing the current operating shortfall to the third quarter of 2022, Alset Capital Acquisition Corp has shown a contraction from $-0.167454 million. This improvement appears promising, but market analysts are still skeptical regarding the overall viability of the company. The central concern lies in whether the entity possesses the required stamina to successfully execute its potential business model.

Alset Capital Acquisition Corp

Alset Capital Acquisition Corp Faces Escalating Concerns Over Alarming Deterioration in Corporate Conduct during Most Recent Fiscal Period



In the Pharmacy Services & Retail Drugstore sector, smaller businesses often take a back seat to larger companies in terms of market attention. However, Alset Capital Acquisition Corp (ACAXU) has recently reported second-quarter financial results that warrant closer examination. While the company is yet to generate any revenue, there are positive indications to suggest that it may be heading towards profitability. This article will delve into the latest financial results of ACAXU, analyze its performance, and speculate on how these factors may impact the company going forward.
1. Operating Loss:
ACAXU reported an operating loss of $-0.236975 million for the second quarter of 2023, which is a cause for concern. It signals that the company's current operations are not generating sufficient revenue to cover its expenses. This is an area that requires attention to ensure sustainable growth in the future.






 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com